NCT04649957

Brief Summary

Currently, there are few studies that have been established that consist of a variety of established and coherent approaches that sought to profile the determinants of recovery, nor used interrogative procedures to understand lasting physical impairment. In this context, measurements obtained from an assessment of cardio-respiratory responses to physiological stress could provide an important insight regarding the integrity of the pulmonary-vascular interface and characterisation of any impairment or abnormal cardio-respiratory function \[4\]. Indeed, current approaches are being developed to support patients using previous knowledge from other acute respiratory infections (e.g. Acute Respiratory Distress Syndrome; ARDS and Middle Eastern Respiratory Syndrome; MERS), approaches that do not consider the novel challenges presented by COVID-19. The knowledge obtained from the proposed research plan will inform the development of COVID-19 specific rehabilitation and clinical management guidelines which can be implemented globally to increase patient wellbeing, physical capacity, and functional status which will be directly related national and international health and wellbeing, economical and societal impacts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 2, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2023

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

2.1 years

First QC Date

December 1, 2020

Last Update Submit

December 20, 2023

Conditions

Keywords

RespiratoryCOVID-19RecoveryFunctional Status

Outcome Measures

Primary Outcomes (1)

  • Post-COVID-19 Functional Status (PCFS) Scale

    The PCFS offers the full spectrum of functional outcomes, and focuses on both limitations in usual duties/activities and changes in lifestyle in six scale grades.

    16 weeks

Secondary Outcomes (1)

  • EQ-5D-5L

    16 weeks

Study Arms (1)

Cohort Observation

Study investigators will identify eligible participants within 72 hours of expected discharge from hospital. Eligibility will be determined using the criteria outlined in section 5.1 which incorporates the Post-COVID-19 Functional Status (PCFS) Scale, a tool which has been developed and endorsed by the European Respiratory Society to measure functional status over time following COVID-19 infection. Patients graded 2, 3 or 4 on the PCFS will be eligible for participation. Eligible patients will be provided with a detailed explanation of the study including the provision of written information (PIS). Patients will be given time to consider participation in the research study before being approached again by the research team. If the patient expresses an interest in study participation the research team will invite participants to a baseline data collection session that will be held at the University of Derby (Kedleston Road campus) in the days following discharge.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study investigators will identify eligible participants within 72 hours of expected discharge from hospital. Eligibility will be determined using the criteria outlined in section 5.1 which incorporates the Post-COVID-19 Functional Status (PCFS) Scale, a tool which has been developed and endorsed by the European Respiratory Society to measure functional status over time following COVID-19 infection. Patients graded 2, 3 or 4 on the PCFS will be eligible for participation. Eligible patients will be provided with a detailed explanation of the study including the provision of written information (PIS). Patients will be given time to consider participation in the research study before being approached again by the research team. If the patient expresses an interest in study participation the research team will invite participants to a baseline data collection session that will be held at the University of Derby (Kedleston Road campus) in the days following discharge.

You may qualify if:

  • Adult patients aged \>18 years, including immunocompromised patients
  • Admitted to hospital for treatment for mild/moderate COVID-19 (from NLR and PLR ratios and grade 2, 3 or grade 4 using PCFS Scale).
  • Chest radiograph/CT scan consistent with COVID-19 infection.
  • Able to understand verbal or written information in English

You may not qualify if:

  • Below 18 years of age
  • No confirmed diagnosis of COVID-19.
  • Achieving a grade 0 or 1 on the PCFS.
  • Not admitted to hospital/critical care for treatment of COVID-19.
  • Reduced or lack of mental capacity
  • Not able to understand verbal or written information in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Derby

Derby, DE22 1GB, United Kingdom

Location

Related Publications (1)

  • Thomas C, Faghy MA, Owen R, Yates J, Ferraro F, Bewick T, Haggan K, Ashton REM. Lived experience of patients with Long COVID: a qualitative study in the UK. BMJ Open. 2023 Apr 26;13(4):e068481. doi: 10.1136/bmjopen-2022-068481.

MeSH Terms

Conditions

Respiratory Tract InfectionsPathological Conditions, Signs and SymptomsCOVID-19

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesPneumonia, ViralPneumoniaVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung Diseases

Study Officials

  • Mark A Faghy, PhD

    University of Derby

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer in Exercise Physiology

Study Record Dates

First Submitted

December 1, 2020

First Posted

December 2, 2020

Study Start

August 1, 2021

Primary Completion

September 6, 2023

Study Completion

December 21, 2023

Last Updated

December 21, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Not part of the study teams plans.

Locations